Cue Biopharma, Inc.

CUE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 14, 2026
4 Oct 14, 2026
4 Oct 14, 2026
144 Oct 13, 2026
144 Oct 13, 2026
SCHEDULE 13G/A Oct 8, 2026
8-K Sep 21, 2026 8-K
4/A Aug 28, 2026
4/A Aug 28, 2026
SCHEDULE 13D Aug 21, 2026
EFFECT Aug 20, 2026
CORRESP Aug 18, 2026
4 Aug 17, 2026
4 Aug 17, 2026
UPLOAD Aug 17, 2026
4 Aug 14, 2026
144 Aug 14, 2026
10-Q Aug 14, 2026 10-Q
8-K Aug 14, 2026 8-K
SCHEDULE 13G Aug 14, 2026
144 Aug 13, 2026
S-3 Aug 12, 2026 S-3
8-K Aug 3, 2026 8-K
4 Aug 3, 2026
3 Aug 3, 2026
← Newer Page 1 of 23 · 552 filings Older →